🟢 Edesa Biotech is trading 8.1% up in pre-market; no company-specific catalyst identified

Edesa Biotech is trading 8.12% up at $5.46 after no clear company-specific announcement was identified for August 7, 2026.

• Its official news page lists releases through June 11, including a private placement; no August 6 or August 7 update is shown.
• The broader market is modestly firmer but does not clearly explain the move; the catalyst remains uncertain pending further filings or disclosures.